AI
IPCI

Atria Investments’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Atria Investments’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7,590
Closed -$159K – 696
2016
Q3 		$159K Buy
7,590
+817
+12% +$14.7K 0.01% 526
2016
Q2 		$106K Buy
6,773
+229
+3% +$4.17K 0.01% 460
2016
Q1 		$134K Buy
+6,544
New +$146K 0.02% 426

Other funds holding IPCI

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atria Investments's IPCI Position: Q4 2016 in Review

Atria Investments sold out of Intellipharmaceuticals International Inc. (IPCI) in Q4 2016, closing a stake of 7,590 shares — an estimated $159K sold.

Atria Investments first reported a position in IPCI in Q1 2016 and held it in 3 quarters. The position peaked at $159K in Q3 2016. 27 funds tracked by Wall St. Rank hold IPCI as of Q4 2016.

  • Atria Investments reported no remaining Intellipharmaceuticals International Inc. position as of Q4 2016 after selling out during the quarter.
  • Atria Investments sold 7,590 Intellipharmaceuticals International Inc. shares in Q4 2016, an estimated $159K.
  • Atria Investments first reported a position in Intellipharmaceuticals International Inc. in Q1 2016 and held it in 3 quarters.
  • Atria Investments's Intellipharmaceuticals International Inc. position peaked at $159K in Q3 2016.
  • 27 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q4 2016.

Based on Atria Investments's 13F filing for Q4 2016, filed 13 Jan 2017.